Comparing robust proton versus online adaptive photon radiotherapy for short-course treatment of rectal cancer

Background and purpose

Image-guided proton beam therapy (IG-PBT) and cone-beam CT (CBCT)-based online adaptive photon radiotherapy (oART) have potentials to restrict radiation toxicity. They are both hypothesised to reduce therapy limiting bowel toxicity in the multimodality treatment of locally advanced rectal cancer (LARC). This study aimed to quantify the difference in relevant dose-volume metrics for these modalities.

Material and Methods

Six-degrees-of-freedom IG-PBT and oART short-course radiotherapy (SCRT) were simulated for 18 LARC patients. Relative biological effectiveness (RBE) was 1.1 for IG-PBT. Delivered dose was evaluated using post-CBCTs. Target coverage was considered robust if average dose to 99% of the clinical target volume was $\ge$ 95% of the prescription. Organ at risk (OAR) doses were compared using dose-volume histograms and severe bowel toxicity estimated using dose–response modelling.

Results

Target coverage was robust in all patients for oART and all but one patient for IG-PBT. For the main OARs, IG-PBT increased the volume exposed to $\ge$ 15 Gy (RBE), but reduced volumes exposed to lower doses. Both low- and high-dose exposure to bowel loops were significantly different between the modalities (median (interquartile range) IG-PBT-V_8.9Gy(RBE) = 92 (51–156) cm³, oART-V_8.9Gy(RBE) = 166 (107–234) cm³, p < 0.001; IG-PBT-V_23Gy(RBE) = 62 (25–106) cm³, oART-V_23Gy(RBE) = 38 (18–75) cm³, p < 0.001), translating into similar total grade ≥ 3 bowel toxicity risk.

Conclusion

IG-PBT and oART delivered comparable and satisfying target coverage in SCRT for LARC with similar estimated risk of severe bowel toxicity. Volumes of OAR exposed to 15 Gy (RBE) or more were reduced by oART, while IG-PBT reduced the volumes receiving doses below this level.